Nuclear Medicine Market Value By Type (Diagnostic, Therapeutic), By Application (Neurology, Thyroid, Oncology), By Procedures (Endocrine, Skeletal, Central Nervous System, Gastrointestinal, Genito-urinary, Pulmonary), By End User (Hospitals, Imaging Centers, Academic & Research Centers), By Region - Industry Share, Statistics & Forecast, 2023 – 2032

  • ID: 131 |  
  • Published date: June, 2023  |  
  • Report Format: PDF

Recent update: Our research team is keeping a close eye on the potential impact of COVID-19 and other global crises on various industries worldwide, allowing us to stay ahead of the competition.

MVI Statistics and Viewpoints:

  • Nuclear Medicine Market size exceeded USD 5.1 Billion in 2022.
  • The market is expected to observe at 12.1% CAGR from 2023 to 2032. 
  • By the end of the forecast period, the industry is anticipated to reach a valuation of around USD 12.5 Billion.

Nuclear Medicine Market

To get more info about this report - 

Nuclear medicine manufacturers are currently focusing on technological advancements, production efficiency, regulatory compliance, supply chain management, collaboration and partnerships, and a patient-centric approach. They aim to develop innovative technologies, streamline production processes, adhere to regulations, ensure a stable supply chain, foster collaborations, and prioritize patient comfort and personalized treatment options.

Market Overview:

The nuclear medicine market encompasses the use of radioactive substances and imaging techniques to diagnose and treat various medical conditions. It combines the fields of nuclear physics, molecular biology, and medical imaging to provide valuable information about the functioning and structure of organs and tissues within the human body. Nuclear medicine plays a critical role in the diagnosis, staging, and treatment of diseases such as cancer, cardiovascular disorders, neurological disorders, and thyroid conditions. The nuclear medicine market is a rapidly evolving field with significant potential for growth and innovation. It plays a crucial role in improving patient outcomes, enabling early disease detection, and providing targeted therapies. Continued advancements in imaging technologies, radiopharmaceutical development, and regulatory frameworks are expected to shape the future of nuclear medicine, further expanding its applications and impact in the field of healthcare.

In the coming years, the market is anticipated to witness growth due to the companies' promising and well-established pipelines of therapeutic radiopharmaceuticals. An example of this is Lantheus Medical Imaging, Inc., which acquired Progenics in June 2020 with the aim of developing groundbreaking medicines and utilizing artificial intelligence to combat cancer. The acquisition, which was initially announced in October 2019, was successfully finalized in June 2020.

Nuclear Medicine Market Value Insights

Report Coverage


Base Year


Market Size in 2022

USD 5.1 Billion

Forecast Period

2023 to 2032

CAGR (2023 to 2032)


Forecast Year Value, 2032

USD 12.5 Billion

Historical Data for

2019 to 2022

Segment Covered

Type, Application, procedure, End Users, Region

Companies Covered

  • Norgine B.V.
  • Lantheus Medical Imaging, Inc
  • Cardinal Health
  • GE Healthcare
  • and more.  


To get more info about this report - 

Growth Drivers:

  • Increasing Prevalence of Cancer and Chronic Diseases: The rising prevalence of cancer and chronic diseases is a significant driver for the nuclear medicine market. Nuclear medicine techniques, such as PET and SPECT imaging, play a crucial role in the early detection, staging, and monitoring of various types of cancer, cardiovascular disorders, neurological diseases, and other chronic conditions. With the growing burden of these diseases globally, there is a higher demand for accurate diagnostic tools that can aid in effective treatment planning and monitoring.
  • Growing Geriatric Population: The aging population is a key driver for the nuclear medicine market. The elderly population is more prone to chronic diseases, including cancer and cardiovascular disorders, which often require advanced imaging and treatment options. Nuclear medicine techniques provide valuable diagnostic and therapeutic tools for this population, aiding in early detection, disease management, and improved patient outcomes.
  • Research and Development: Ongoing research and development activities contribute to the growth of the nuclear medicine market. Investments in developing new radiopharmaceuticals, imaging agents, and therapeutic approaches expand the applications and capabilities of nuclear medicine. Additionally, collaborations between pharmaceutical companies, academic institutions, and imaging centers drive innovation and the introduction of novel technologies into clinical practice.

By End Users Synopsys:  

The market is segmented based on end users, including hospitals, academic & research centers, imaging centers, and other end users such as pharma/biotech companies and contract research organizations. In 2022, the hospital segment held the largest market share, driven by the rising number of diagnostic imaging procedures conducted in hospitals and the growing need for early disease detection.

North America Market Analysis:

Nuclear Medicine Market Size

To get more info about this report - 

North America nuclear medicine market held over 36% of the revenue share in 2022 due to the presence of a large number of nuclear medicine centers in the region, as well as the availability of advanced nuclear medicine technologies. Moreover, Europe is the second-largest market for nuclear medicine. The market in Europe is driven by the increasing prevalence of chronic diseases such as cancer, heart disease, and neurological disorders.

Asia Pacific Market Analysis

Asia Pacific is the fastest-growing market for nuclear medicine. The growth of the market in Asia Pacific is attributed to the rising awareness about nuclear medicine, the increasing number of nuclear medicine centers in the region, and the growing government support for nuclear medicine research and development.

Key Development:

  • In 2023, NorthStar Medical Radioisotopes has made significant progress in the development of its innovative technology for producing the essential medical radioisotope, molybdenum-99, without relying on uranium. 
  • In 2022, Blue Earth Diagnostics has entered into a data-sharing agreement with Siemens Healthineers and the Technical University of Munich. The agreement aims to facilitate the development of AI-based algorithms by utilizing data from 18F-rhPSMA-7.3, an investigative PET imaging agent. This collaboration will support advancements in the field of medical imaging.

Top companies includes in the global nuclear medicine market:

  • Norgine B.V.
  • Lantheus Medical Imaging, Inc
  • Cardinal Health 
  • GE Healthcare 
  • Nordion (Canada) Inc
  • Bayer AG 
  • Jubilant Pharmova Limited
  • Curium 
  • Advanced Accelerator Applications
  • Bracco Diagnostic Inc. 
  • Others

To get more info about this report - 

In-depth analysis of nuclear medicine market along with industry coverage and forecasting for the following segments:

Market Size, By Type

  • Diagnostic
  • Therapeutic

Market Size, By Application

  • Neurology
  • Thyroid
  • Oncology

Market Size, By Procedures

  • Endocrine
  • Skeletal
  • Central Nervous System
  • Gastrointestinal
  • Genito-urinary
  • Pulmonary

Market Size, By End User 

  • Hospitals
  • Imaging Centers
  • Academic & Research Centers
  • Others

Market Size, By Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Frequently Asked Questions (FAQ):

Publisher: Market Value Insights


  • $3500

  • $4500
  • $5500

Get in Tuch With Us